# Aurigene Oncology

Source: https://onco.cc/companies/aurigene/  
OnCo record `aurigene` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Dr. Reddy's oncology discovery company, with more than 20 programmes in clinical development worldwide through partners and its own small-molecule and cell therapy pipeline.

## Summary

Aurigene was established in 2001 as a discovery subsidiary of Dr. Reddy's Laboratories and now describes itself as a clinical-stage biopharmaceutical company focused on cancer therapeutics, with more than 80 integrated discovery projects delivered, 22 programmes in global clinical development and a team of over 350 scientists in Bengaluru and Hyderabad. Its model has been to discover molecules against validated cancer targets and partner them with global companies for clinical development, while building an Indian pipeline that includes a BCMA-directed CAR-T for multiple myeloma developed for the Indian market.

## Fields

- Kind: Company
- Last checked: 2026-09-10
- HQ: Bengaluru
- Type: biotech
- Website: https://www.aurigene.com

## Sources

- Official website: https://www.aurigene.com

## Connected records

- cancers: [Multiple myeloma](https://onco.cc/cancers/multiple-myeloma/)
- fronts: [Cell Therapy](https://onco.cc/fronts/cell-therapy/), [Drug Discovery Platforms](https://onco.cc/fronts/drug-discovery/)
- technologies: [CAR-T cell therapy](https://onco.cc/technologies/car-t/), [Small-molecule kinase inhibitors](https://onco.cc/technologies/kinase-inhibitors/)
- targets: [BCMA](https://onco.cc/targets/bcma/)
- companies: [Dr. Reddy's Laboratories](https://onco.cc/companies/dr-reddys/)
- bottlenecks: [The valley of death between lab and product](https://onco.cc/bottlenecks/b-translational-valley/)

---
JSON: https://onco.cc/api/v1/entities/aurigene.json